<?xml version="1.0" encoding="UTF-8"?>
<notes notes-type="COI-statement" class="notes">
 <sec id="FPar3" class="sec">
  <title class="title">Ethics approval and consent to participate</title>
  <p class="p">
   <italic class="italic">C. sativa</italic> var. Bedrobinol plants were supplied by Bedrocan BV (Veendam, Netherlands) and 
   <italic class="italic">C. sativa</italic> var. Fedora seeds were acquired from Botanik Sämereien GmbH (Wädenswil, Switzerland). Studies were conducted with the permissions of No. 458 64 16 and 458 49 89 issued by the Federal Institute for Drugs and Medical Devices (BfArM), Germany.
  </p>
 </sec>
 <sec id="FPar4" class="sec">
  <title class="title">Consent for publication</title>
  <p class="p">Not applicable as the manuscript contains no individual identifying data.</p>
 </sec>
 <sec id="FPar5" class="sec">
  <title class="title">Competing interests</title>
  <p class="p">The authors declare that they have no competing interests.</p>
 </sec>
 <sec id="FPar6" class="sec">
  <title class="title">Publisher’s Note</title>
  <p class="p">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
 </sec>
</notes>
